[Changing pattern and prevention of infectious diseases complicated with severe hematologic diseases].
Funada
H
H
D000212:Acyclovir / Q000627:therapeutic use; D000666:Amphotericin B / Q000627:therapeutic use; D016470:Bacteremia / Q000382:microbiology* / Q000517:prevention & control; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000150:complications*; D006566:Herpesviridae Infections / Q000382:microbiology* / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D009164:Mycobacterium Infections / Q000382:microbiology* / Q000517:prevention & control; D009181:Mycoses / Q000382:microbiology* / Q000517:prevention & control
D016179:Granulocyte Colony-Stimulating Factor; D000666:Amphotericin B; D000212:Acyclovir